ZYBT
Zhengye Biotechnology Holding Limited
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$1.61
−1.23%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.29x
- Price / sales
- 2.76x
- Price / cash flow
- 24.08x
Enterprise value
- Enterprise value
- $59.8M
- EV / sales
- 3.45x
- EV / EBITDA
- -9.44x
- EV / EBIT
- -5.88x
- Market cap
- $47.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025